We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Overexpression of molecular chaperons GRP78 and GRP94 in CD44<sup>hi</sup>/CD24<sup>lo</sup> breast cancer stem cells.
- Authors
Nami, Babak; Ghasemi-Dizgah, Armin; Vaseghi, Akbar
- Abstract
Introduction: Breast cancer stem cell with CD44hi/CD24lo phonotype is described having stem cell properties and represented as the main driving factor in breast cancer initiation, growth, metastasis and low response to anti-cancer agents. Glucoseregulated proteins (GRPs) are heat shock protein family chaperons that are charged with regulation of protein machinery and modulation of endoplasmic reticulum homeostasis whose important roles in stem cell development and invasion of various cancers have been demonstrated. Here, we investigated the expression levels of GRP78 and GRP94 in CD44hi/CD24lo phenotype breast cancer stem cells (BCSCs). Methods: MCF7, T-47D and MDA-MB-231 breast cancer cell lines were used. CD44hi/CD24lo phenotype cell population were analyzed and sorted by fluorescence-activated cell sorting (FACS). Transcriptional and translational expression of GRP78 and GRP94 were investigated by western blotting and quantitative real time PCR. Results: Results showed different proportion of CD44hi/CD24lo phenotype cell population in their original bulk cells. The ranking of the cell lines in terms of CD44hi/CD24lo phenotype cell population was as MCF7<T-47D<MDA-MB-231. Our results also indicated that CD44hi/CD24lo phenotype cells exhibited higher mRNA and protein expression level of GRP78 and GRP94 compared to their original bulk cells. Conclusion: Our results show a relationship between overexpression of GRP78 and GRP94 and exhibiting CD44hi/CD24lo phenotype in breast cancer cells. We conclude that upregulation of GRPs may be an important factor in the emergence of CD44hi/CD24lo phenotype BCSCs features.
- Subjects
BREAST cancer treatment; STEM cell treatment; MOLECULAR chaperones; GENETIC overexpression; ANTINEOPLASTIC agents; WESTERN immunoblotting
- Publication
BioImpacts, 2016, Vol 6, Issue 2, p105
- ISSN
2228-5652
- Publication type
Article
- DOI
10.15171/bi.2016.15